Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome

Urology

Volumn 54, Issue 1, 1999, Pages 97-104

  Bogers, Hans A ^a   Sedelaar, J P Michiel ^a   Beerlage, Harrie P ^a   De La Rosette, Jean J M C H ^a   Debruyne, Frans M J ^a   Wijkstra, Hessel ^a   Aarnink, Rene G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SHU 508;

ANGIOGRAPHY; ARTICLE; B SCAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; GRAY SCALE ECHOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; VASCULARIZATION;

ANGIOGRAPHY; BIOPSY; CONTRAST MEDIA; HUMANS; MALE; POLYSACCHARIDES; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0033169093     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00040-0     Document Type: Article

References (34)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics 1997. CA Cancer J Clin 47: 5-27, 1997.
2. Miller BA, Ries Gloeckler LA, Honkey BF, et al (Eds): Cancer Statistics Review 1973-1989. NIH publication No. 92-2789. Bethesda, National Cancer Institute, 1992, pp 11-13.
3. Littrup PJ, Kane RA, Mettlin CJ, et al: Cost-effective prostate cancer detection: reduction of low-yield biopsies. Cancer 74: 3146-3158, 1994.
4. Aus G, Hermansson CG, Hugosson J, et al: Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 71: 457-459, 1993.
5. Collins GN, Lloyd SN, Hekir M, et al: Multiple transrectal ultrasound-guided biopsies - true morbidity and patient acceptance. Br J Urol 71: 460-463, 1993.
6. Beerlage HP, De Reijke TM, and de la Rosette JJMCH: Considerations regarding prostate biopsies. Eur Urol 34: 303-312, 1998.
7. Giesen RJB, Huynen AL, Aarnink RG, et al: Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 154: 1397-1400, 1995.
8. Chodak GW, Wald V, Parmer E, et al: Comparison of digital rectal examination and transrectal ultrasonography for the diagnosis of prostatic cancer. J Urol 135: 951-954, 1986.
9. Rifkin MD, and Choi H: Endorectal prostate ultrasound: implications of the small peripherally placed hypoechoic lesion. Radiology 166: 619-622, 1988.
10. Lee F, Torp-Pedersen ST, Siders DB, et al: Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 170: 609-615, 1989.
11. Chodak GW, and Schoenberg HW: Progress and problems in screening for carcinoma of the prostate. World J Surg 13: 60-64, 1989.
12. Ragde H, Bagely CM Jr, Aldape HC, et al: Prostate cancer screening with high-resolution transrectal ultrasound. J Endourol 3: 115-123, 1989.
13. Terris EK, Freiha ES, McNeal JE, et al: Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 146: 78-83, 1991.
14. Oyen R, Van Popel H, Vandevoorde W, et al: The significance of local hypoechoic lesions in the peripheral zone of the prostate. J Belge Radiol 78: 356-358, 1995.
15. Sibley RI, and Sibley AF: Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans. J Natl Med Assoc 89: 318-323, 1997.
16. Kelly IMG, Lees WR, and Rickards D: Prostate cancer and the role of color Doppler US. Radiology 189: 153-156, 1993.
17. Rifkin MD, Sudakoff GS, and Alexander AA: Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 186: 509-513, 1993.
18. Cornud F, Belin X, Piron D, et al: Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49: 709-715, 1997.
19. Newman JS, Bree RL, and Rubin JM: Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195: 86-90, 1995.
20. Patel U, and Rickards D: The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 74: 590-595, 1994.
21. Cho JY, Kim SH, and Lee SE: Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography. J Ultrasound Med 17: 283-287, 1998.
22. Ismail M, Petersen RO, Alexander AA, et al: Color Doppler imaging in predicting the biologic behaviour of prostate cancer: correlation with disease-free survival. Urology 50: 906-912, 1997.
23. Bree RL: The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49(3A suppl): 31-34, 1997.
24. Lavoipierre AM, Snow RM, Frydenberg M, et al: Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171: 205-210, 1998.
25. Schlief R, Staks T, Mahler M, et al: Successfull opacification of the left heart chambers on echocardiographic examination of a new saccharide based contrast agent. Echocardiography 7: 1-4, 1990.
26. Neumaier CE, Martinoli C, Derchi LE, et al: Normal prostate gland: examination with color Doppler US. Radiology 196: 453-457, 1995.
27. Kirby RS: Pre-treatment staging of prostate cancer: recent advances and future prospects. Prostate Cancer Prostatic Dis 1: 2-10, 1997.
28. Aarnink RG, Beerlage HB, de la Rosette JJMCH, et al: Transrectal ultrasound of the prostate: innovations and future applications. J Urol 159: 1568-1579, 1998.
29. Burns PN, Hilpert P, and Goldberg BB: Intravenous contrast agent for ultrasound Doppler: in vivo measurement of small vessel dose-response. IEEE Eng Med Biol Soc 12: 322-324, 1990.
30. Aarnink RG, Beerlage HP, de la Rosette JJMCH, et al: Contrast angiosonography: a technology to improve Doppler ultrasound examinations of the prostate. Eur Urol 35: 9-20, 1999.
31. Kedar RP, Cosgrove D, McCready VR, et al: Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 198: 679-686, 1996.
32. Ragde H, Kenny GM, Murphy GP, et al: Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate 32: 279-283, 1997.
33. Watanabe M: Color Doppler enhancement with contrast agents for the detection of prostatic cancer. Nippon Rinsho 56: 1040-1044, 1998.
34. Fenster A, Lee D, Sherebrin S, et al: Three-dimensional ultrasound imaging of the vasculature. Ultrasonics 36: 629-633, 1998.